BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 191 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $2,118,000 | -4.9% | 62,245 | +16.7% | 3.37% | +296.8% |
| Q3 2019 | $2,226,000 | -22.1% | 53,345 | -18.2% | 0.85% | -9.3% |
| Q2 2019 | $2,857,000 | -27.3% | 65,249 | -14.6% | 0.94% | -8.4% |
| Q1 2019 | $3,931,000 | +0.6% | 76,379 | -27.7% | 1.02% | -20.3% |
| Q4 2018 | $3,909,000 | -1.5% | 105,706 | 0.0% | 1.28% | +46.6% |
| Q3 2018 | $3,969,000 | -5.0% | 105,706 | 0.0% | 0.88% | -2.7% |
| Q2 2018 | $4,178,000 | +53.4% | 105,706 | 0.0% | 0.90% | +51.8% |
| Q1 2018 | $2,723,000 | -4.5% | 105,706 | 0.0% | 0.59% | -25.9% |
| Q4 2017 | $2,852,000 | +280.3% | 105,706 | +252.4% | 0.80% | +226.5% |
| Q2 2017 | $750,000 | – | 30,000 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |